Avid Bioservices Inc (CDMO)

[jakedogman1]

If I can recall on the last cc, an analyst asked about rev guidance on a qtr to qtr basis. Mgmt said the rev would be uneven given the annual maint shutdown for qtr 2and the rev for year would be weighted towards the second half of the year. I don't expect the 2nd qtr to be good but what I want to see is guidance going forward. Halo is now focused on enhanze and bavi started a couple of trials which should help avid rev's. It is time for them to deliver.